Selective laser trabeculoplasty as the initial treatment of primary open-angle glaucoma
https://doi.org/10.25700/NJG.2020.01.07
Abstract
Selective laser trabeculoplasty (SLT) is a relatively new method of intraocular pressure lowering in patients with primary open-angle glaucoma (POAG). The main advantages of SLT are its safety and effectiveness. Laser methods are considered to be the second line of glaucoma treatment worldwide. Hyportensive drugs are usually used as the initial method for glaucoma patients. It is common knowledge that preservatives and active components of eye drops usually cause adverse effects. This problem is especially relevant in patients with POAG due to the need for lifelong therapy starting from the moment of proving the diagnosis. In addition, the mechanisms of interaction between antiglaucoma drugs and medications for extraocular diseases remain unclear. Therefore, the question of initial SLT in patients with newly diagnosed POAG remains essentially important. In our review we compared the methods of selective laser trabeculoplasty and drug therapy in glaucoma treatment, analyzing available information regarding indications, contraindications, complications and effectiveness of the methods, patients’ quality of life and economic aspects.
About the Authors
V. P. Erichev
Scientific Research Institute of Eye Diseases
Russian Federation
Med.Sc.D., Professor, Head of Glaucoma Department
Russian Federation
Med.Sc.D., Professor, Head of Glaucoma Department
E. A. Ragozina
Scientific Research Institute of Eye Diseases
Russian Federation
resident
Russian Federation
resident
References
1. Quigley H.A. Clinical trials for glaucoma neuroprotection are not impossible. Curr Opin Ophthalmol. 2012; 23(2):144–154. doi: 10. 1097/ICU.0b013e32834ff490
2. Bolshunov A.V. Voprosy lazernoj oftal'mologii [The Issues of laser of ophthalmology]. Moscow: April; 2013. 316 p.
3. European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options. Br J Ophthalmol. 2017; 101:130-195.
4. Guglielmi P., Carradori S., Campestre C., Poce G. Novel therapies for glaucoma: a patent review (2013-2019), Exper Opin Therapeutic Patents. 2019; 29(10):769-780. doi: 10.1080/13543776.2019.1653279
5. Anderson R.R., Parrish J.A. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983; 220:524–527. doi: 10.1126/science.6836297
6. Latina M.A., Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res. 1995; 60:359-371. doi: 10.1016/s0014-4835(05)80093-4
7. Kagan D.B., Gorfinkel N.S., Hutnik C.M. Mechanisms of selective laser trabeculoplasty: a review. Clin Exp Ophthalmol. 2014; 42:675-681. doi: 10.1111/ceo.12281
8. Garg A., Gazzard G. Selective laser trabeculoplasty: past, present, and future. Eye. 2018; 32:863-876. doi: 10.1038/eye.2017.273
9. Kramer T.R., Noecker R.J. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology. 2001; 108:773–779. doi: 10.1016/s0161-6420(00)00660-6
10. Cvenkel B., Hvala A., Drnovsek-Olup B., Gale N. Acute ultrastructural changes of the trabecular meshwork after selective laser trabeculoplasty and low power argon laser trabeculoplasty. Lasers Surg Med. 2003; 33:204–208. doi: 10.1002/lsm.10203
11. SooHoo J.R., Seibold L.K., Ammar D.A., Kahook M.Y. Ultrastructural changes in human trabecular meshwork tissue after laser trabeculoplasty. J Ophthalmol. 2015; 2015:476138. doi: 10.1155/2015/476138
12. Alvarado J.A., Iguchi R., Martinez J., Trivedi S., Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells. Am J Ophthalmol. 2010; 150:254–264. doi: 10.1016/j.ajo.2010.03.012
13. Hirabayashi M.T., Rosenlof T.L., An J.A. Comparison of successful outcome predictors for MicroPulse® laser trabeculoplasty and selective laser trabeculoplasty at 6 months. Clin Ophthalmol. 2019; 13:1001– 1009. doi: 10.2147/OPTH.S205977
14. Ayala M., Enping C. Predictive factors of success in selective laser trabeculoplasty (SLT) treatment. Clin Ophthalmol. 2011; 5:573–576. doi: 10.2147/OPTH.S19873
15. Hodge W.G., Damji K.F., Rock W., Buhrmann R. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol. 2005; 89(9):1157– 1160. doi: 10.1136/bjo.2004.062414
16. Shazly T.A., Latina M.A., Dagianis J.J., Chitturi S. Effect of prior cataract surgery on the long-term outcome of selective laser trabeculoplasty. Clin Ophthalmol. 2011; 5:377-80. doi: 10.2147/OPTH.S17237
17. Lee J.W., Wong M.O., Wong R.L., Lai J.S. Correlation of intraocular pressure between both eyes after bilateral selective laser trabeculoplasty in open-angle glaucoma. J Glaucoma. 2016; 25(3):248–252. doi: 10.1097/IJG.0000000000000274
18. Shazly T.A., Latina M.A. Intraocular pressure response to selective laser trabeculoplasty in the first treated eye vs the fellow eye. Arch Ophthalmol. 2011; 129(6):699-702. doi: 10.1001/archophthalmol.2011.108
19. Shazly T.A., Latina M.A., Dagianis J.J., Chitturi S. Effect of central corneal thickness on the long-term outcome of selective laser trabeculoplasty as primary treatment for ocular hypertension. Cornea. 2012; 31:883–886. doi: 10.1097/ICO.0b013e318243f684
20. Hirneiss C., Sekura K., Brandlhuber U., Kampik A. Corneal biomechanics predict the outcome of selective laser trabeculoplasty in medically uncontrolled glaucoma. Graefes Arch Clin Exp Ophthalmol. 2013; 251:2383–2388. doi: 10.1007/s00417-013-2416-2
21. Martow E., Hutnik C.M., Mao A. SLT and adjunctive medical therapy: a prediction rule analysis. J Glaucoma. 2011; 20:266–270. doi: 10.1097/IJG.0b013e3181e3d2c1
22. Woo D.M., Healey P.R., Graham S.L., Goldberg I. Intraocular pressurelowering medications and long-term outcomes of selective laser trabeculoplasty. Clin Exp Ophthalmol. 2015; 43:320-327. doi: 10.1111/ ceo.12452
23. Lee J.W., Liu C.C., Chan J., Wong R.L., Predictors of success in selective laser trabeculoplasty for primary open angle glaucoma in Chinese. Clin Ophthalmol. 2014; 8:1787–1791. doi: 10.2147/OPTH. S69166
24. Bruen R., Lesk M.R., Harasymowycz P. Baseline factors predictive of SLT response: a prospective study. J Ophthalmol. 2012; 2012: 642869. doi: 10.1155/2012/642869
25. Pillunat K.R., Spoerl E., Elfes G., Pillunat L.E. Preoperative intraocular pressure as a predictor of selective laser trabeculoplasty efficacy. Acta Ophthalmol. 2016; 94:692–696. doi: 10.1111/aos.13790
26. Lee J.W., Ho W.L, Chan J.C., Lai J.S. Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results. BMC Ophthalmol. 2015; 15:1. doi: 10.1186/1471-2415-15-1
27. Lee J.W., Shum J.J., Chan J.C., Lai J.S. Two-year clinical results after selective laser trabeculoplasty for normal tension glaucoma. Medicine (Baltimore). 2015; 94(24):984. doi: 10.1097/MD.0000000000000984
28. Alon S. Selective laser trabeculoplasty: a clinical review. J Curr Glaucoma Pract. 2013; 7(2):58–65. doi: 10.5005/jp-journals-10008-1139
29. Egorov E.A. Glaukoma. Natsional'noe rukovodstvo. [Glaucoma. National Guideline]. Moscow: GEOTAR-Media; 2013. 824 p. (In Russ.).
30. Erichev V.P., Makarova A.S. Compatibility of systemic drugs and local antihypertensive therapy in patients with primary open-angle glaucoma (analytical review). Ophthalmology in Russia. 2018; 15(4):366- 373. (In Russ.). doi: 10.18008/1816-5095-2018-4-366-373
31. Ang M., Tham C.C., Sng C.C.A. Selective laser trabeculoplasty as the primary treatment for open-angle glaucoma: time for change? Eye. 2019. doi: 10.1038/s41433-019-0625-6
32. Lai J.S., Chua J.K., Tham C.C., Lam D.S. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Exper Ophthalmol. 2004; 32:368–372. doi: 10.1111/j.1442-9071.2004.00839.x
33. Nagar M., Luhishi E., Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. Br J Ophthalmol. 2009; 93:497–501. doi: 10.1136/bjo.2008
34. Li X., Wang W., Zhang X.. Meta-analysis of selective laser trabeculoplasty versus topical medication in the treatment of open-angle glaucoma. BMC Ophthalmol. 2015; 5:107. doi: 10.1186/s12886-015-0091-2
35. Wong M.O., Lee J.W., Choy B.N., Chan J.C. et al. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol. 2015; 60:36–50. doi: 10.1016/j.survophthal.2014.06.006
36. De Keyser M., De Belder M., De Groot V. Randomized prospective study of the use of anti-inflammatory drops after selective laser trabeculoplasty. J Glaucoma. 2017; 26:22-29. doi: 10.1097/IJG.0000000000000522
37. Harasymowycz P.J., Papamatheakis D.G., Latina M., De Leon M. et al. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. Am J Ophthalmol. 2005; 139:1110–1113. doi: 10.1016/j.ajo.2004.11.038
38. Zhang L., Weizer J.S., Musch D.C. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty. Cochrane Database Syst Rev. 2017; 2(2):CD010746. doi: 10.1002/14651858.CD010746.pub2
39. Song J. Complications of selective laser trabeculoplasty: a review. Clin Ophthalmol. 2016; 10:137–143. doi: 10.2147/OPTH.S84996
40. Liyanage S.E., Kumaran N., De Alwis D. Macular burns resulting from the accidental use of selective laser trabeculoplasty mode during a laser capsulotomy. Br J Ophthalmol. 2014; 98:141–142. doi: 10.1136/ bjophthalmol-2013-303489
41. Lee J.W., Chan J.C., Chang R.T., Singh K. et al. Corneal changes after a single session of selective laser trabeculoplasty for open-angle glaucoma. Eye. 2014; 28(1):47–52. doi:10.1038/eye.2013.23
42. Latina M.A., Tumbocon J.A. Selective laser trabeculoplasty: a new treatment option for open angle glaucoma. Curr Opin Ophthalmol. 2002; 13(2):94–96. doi: 10.1097/00055735-200204000-00007
43. Knickelbein J.E., Singh A., Flowers B.E., Unni K.N. et al. Acute corneal edema with subsequent thinning and hyperopic shift following selective laser trabeculoplasty. J Cataract Refract Surg. 2014; 40(10):1731– 1735. doi: 10.1016/j.jcrs.2014.08.002
44. Wolfram C., Stahlberg E., Pfeiffer N. Patient-reported nonadherence with glaucoma therapy. J Ocul Pharmacol Ther. 2019; 35(4):223–228. doi: 10.1089/jop.2018.0134
45. Gazzard G., Konstantakopoulou E., Garway-Heath D., Garg A. et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019; 393(10180):1505-1516. doi: 10.1016/S0140-6736(18)32213-X
46. De Keyser M., De Belder M., De Groot V. Quality of life in glaucoma patients after selective laser trabeculoplasty. Int J Ophthalmol. 2017; 10:742–748. doi: 10.18240/ijo.2017.05.14
47. Gazzard G., Konstantakopoulou E., Garway-Heath D., Barton K. et al. Laser in glaucoma and ocular hypertension (light) trial. A multicentre, randomised controlled trial: design and methodology. Br J Ophthalmol. 2018; 102:593–598. doi: 10.1136/bjophthalmol-2017-310877
48. Ang G.S., Fenwick E.K., Constantinou M., Gan A. et al. Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial. Br J Ophthalmol. 2019; Sep. 5:1–9. doi: 10.1136/bjophthalmol-2018-313396
49. Chuprov A.D., Kanyukov V.N., Kadnikova O.V., Ekimov A.K. Economic effectiveness of selective trabeculoplasty. Natsional'nyi zhurnal glaucoma. 2017; 16(3): 36-42. (In Russ.).
Review
For citations:
Erichev V.P., Ragozina E.A. Selective laser trabeculoplasty as the initial treatment of primary open-angle glaucoma. National Journal glaucoma. 2020;19(1):47-54. (In Russ.) https://doi.org/10.25700/NJG.2020.01.07
Views:
1749
Email this article 